The Institut Curie, the first French center for the fight against cancers, and the Diaconesses Hospital Group Croix Saint Simon, founder of the Center of Cancer in eastern Paris, announce the creation of a strategic partnership. Called “Expert Institut Curie / Diaconesses Croix Saint Simon Institute”, this new partnership associates the expertise of the two establishments to offer patients an optimized care path and access to treatment of excellence.
For patients: a coordinated and fluid course, with access to innovation
Thanks to the creation of this new expert course, patients with cancer welcomed by the Institut Curie and by the Cancer Center of East Parisian will benefit from the management of excellence, fast and coordinated between the two hospitals.
Bring together the best of two hospitals of excellence in cancerology
This integrated and unprecedented expert course will relate in particular to precision radiotherapy, an area for which the Curie Institute is a precursor, at the forefront of innovation with the most complete plateau in Europe and rupture research projects.
In terms of therapeutic efficiency still, surgery is a key step in management; It is also an area of excellence at the Center de Cancer East Parisian, authorized to practice all carcinological surgeries, including complexes.
The analysis and characterization of tumors are also a strong axis of this new alliance thanks to the expertise of anatomopathology teams of the Curie Institute, especially in artificial intelligence. The Cancer Center of Eastern Parisian offers it emergency screening devices that have proven themselves, with unique protocols for certain cancers incorporating artificial intelligence to optimize the identification of tumors.
The Curie-Diaconesses Croix Saint Simon expert course allows you to bring together and coupled the advantages of the two structures so that patients have access to the best diagnostics, then to the best care.
At first, the Expert Institut Curie / Diaconnese Croix St-Simon course is dedicated to patients with urological cancer, gynecological and breast cancer for which the Curie Institute is the first European care center and the Center for Cancer in eastern Parisian one of the most recognized establishments in France.
Excellence treatments at each stage of the expert course
Diagnostics and cutting -edge screenings
This unique expert course will allow patients to benefit:
- rapid screening devices, such as breast emergencies and onco-divigestive emergencies of the Cancer Center in eastern Parisian
- Innovative diagnostic protocols practiced at the Cancer Center in eastern Paris, integrating artificial intelligence for a finer location of certain tumors, whatever their size and including for the least advanced stages of tumor tumor transformation
- Strong expertise in anatomopathology and digital pathology of the Curie Institute, which has a vast pole of expertise in pathology, entirely digitized allowing exchanges facilitated around virtual blades. The Curie Institute is a pioneer in digital pathology: by associating digitization of very fine cuts of tumors and artificial intelligence tools, this expertise contributes to ever more precise diagnoses, even more relevant therapeutic decisions.
Access to the latest therapeutic and technological innovations
Patients will also have access to excellence care within this integrated expert course:
- Radiation therapy, for which the expertise of the Curie Institute in terms of management and innovation but also research is recognized
- Carcinological surgery, which the Cancer Center in eastern Parisian, equipped with a latest generation surgical robot, realizes with excellence, including complex surgeries and those of rare women, which few establishment in France have the authorization to practice.
- Clinical immunology: with identification by experts from the Institut Curie des Biomarquers predictive of a clinical response in terms of efficiency and toxicity
- Chemotherapy, thanks to anti-cancer preparation units located in each hospital, and the arrival of a second insulator at the GH Diaconesses Croix St-Simon to streamline chemotherapy and facilitate their administration.
For French research: accelerate the discovery of new treatments
This partnership will strengthen collaboration in research and innovation. The 4,000 researchers, doctors, surgeons and caregivers specializing in oncology of the two establishments will unite their forces to advance knowledge and practices in cancerology.
This synergy aims to accelerate discoveries and improve treatments, thus offering patients the hope of better care and new therapeutic perspectives, especially in chemotherapy, radiotherapy and anatomopathology.
“This strong partnership illustrates our common desire to provide a response adapted to the needs of patients, by combining medical excellence, organizational efficiency, research and innovation. Together, we lay the foundations for a lasting model of ambitious cooperation, at the service of expert support in the fight against cancer.”
Pr Steven Le Gouill, director of the hospital ensemble of the Institut Curie
“The collaboration between our hospitals is based on the values of solidarity and excellence in the health we share. This unique route is accessible to all patients, so that everyone benefits from excellence care and the latest therapeutic innovations, without any excess of fee.”
Guillaume Chesnel, Managing Director of GH Diaconesses Croix St-Simon
